In STEMI, C-reactive protein at presentation predicts MI, death

January 19, 2013
In STEMI, C-reactive protein at presentation predicts MI, death
For patients with ST-segment elevation myocardial infarction, high-sensitivity C-reactive protein measurements at presentation predict subsequent nonfatal myocardial infarction and cardiac death; and for patients with acute coronary syndromes, fetuin-A and C-reactive protein have prognostic value, according to two studies published in the Jan. 1 issue of The American Journal of Cardiology.

(HealthDay)—For patients with ST-segment elevation myocardial infarction (STEMI), high-sensitivity C-reactive protein (hsCRP) measurements at presentation predict subsequent nonfatal MI and cardiac death; and for patients with acute coronary syndromes (ACS), fetuin-A and CRP have prognostic value, according to two studies published in the Jan. 1 issue of The American Journal of Cardiology.

Stamatis S. Makrygiannis, M.D., from the "Tzanio" Hospital of Piraeus in Greece, and colleagues determined hsCRP measurements at presentation and at 24, 48, and 72 hours in 861 patients admitted for STEMI who received intravenous thrombolytic therapy within the first six hours of the index pain. Over a median follow-up of 3.5 years, the researchers found that hsCRP levels at presentation independently predicted nonfatal MI and cardiac death (relative risk, 2.8 and 2.1, respectively), while levels at 24 hours predicted neither. Levels of hsCRP at 48 and 72 hours significantly predicted cardiac death (relative risk, 3.2 and 3.9, respectively) but not MI.

Pascal Lim, M.D., Ph.D., from the AP-HP-University Hospital Henri Mondor in Creteil, France, and colleagues examined the prognostic value of fetuin-A adjusted for CRP value and Global Registry of Acute Coronary Events in 754 patients with ACS. The researchers found that the one-year was 10 percent overall, 17 percent for those with low-fetuin-A, 18 percent for those with high CRP, 23 percent for those with low fetuin-A and high CRP, and 5 percent for those with neither low fetuin-A nor high CRP.

"In this large cohort of patients, we demonstrate that a severe inflammatory imbalance, characterized by a low fetuin-A concentration (anti-) and a high CRP concentration, is associated with a higher risk for death after ACS," Lim and colleagues write.

Several authors from the Lim study disclosed financial ties to the pharmaceutical industry.

Explore further: Fetuin-A levels linked to cardiovascular disease risk

More information: Abstract - Makrygiannis
Full Text
Abstract - Lim
Full Text

Related Stories

Fetuin-A levels linked to cardiovascular disease risk

January 8, 2013
(HealthDay)—In elderly individuals without type 2 diabetes, high levels of fetuin-A, a protein that inhibits arterial calcification and insulin action, is associated with a lower risk of cardiovascular disease, according ...

Solution does not reduce rate of progression to development of heart attack after chest pain

March 27, 2012
Patients experiencing symptoms such as chest pain who received from paramedics an intravenous solution consisting of glucose-insulin-potassium (GIK) had no reduction in the rate of progression to heart attack and no improvement ...

Uric acid levels predict death in acute coronary syndrome

April 20, 2012
(HealthDay) -- Elevated uric acid levels are predictive of one-year mortality in patients with acute coronary syndrome, according to a study published in the May 1 issue of The American Journal of Cardiology.

Low vitamin C levels may raise heart failure patients' risk

November 13, 2011
Low levels of vitamin C were associated with higher levels of high sensitivity C-Reactive protein (hsCRP) and shorter intervals without major cardiac issues or death for heart failure patients, in research presented at the ...

Recommended for you

Starting periods before age of 12 linked to heightened risk of heart disease and stroke

January 15, 2018
Starting periods early—before the age of 12—is linked to a heightened risk of heart disease and stroke in later life, suggests an analysis of data from the UK Biobank study, published online in the journal Heart.

'Decorated' stem cells could offer targeted heart repair

January 10, 2018
Although cardiac stem cell therapy is a promising treatment for heart attack patients, directing the cells to the site of an injury - and getting them to stay there - remains challenging. In a new pilot study using an animal ...

Exercise is good for the heart, high blood pressure is bad—researchers find out why

January 10, 2018
When the heart is put under stress during exercise, it is considered healthy. Yet stress due to high blood pressure is bad for the heart. Why? And is this always the case? Researchers of the German Centre for Cardiovascular ...

Two simple tests could help to pinpoint cause of stroke

January 10, 2018
Detecting the cause of the deadliest form of stroke could be improved by a simple blood test added alongside a routine brain scan, research suggests.

Heart-muscle patches made with human cells improve heart attack recovery

January 10, 2018
Large, human cardiac-muscle patches created in the lab have been tested, for the first time, on large animals in a heart attack model. This clinically relevant approach showed that the patches significantly improved recovery ...

Place of residence linked to heart failure risk

January 9, 2018
Location. Location. Location.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.